featured
Antitumor Activity of Lurbinectedin in Relapsed Ewing Sarcoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Relapsed Ewing Sarcoma: Results of a Basket Phase II Study
Clin. Cancer Res 2022 Apr 29;[EPub Ahead of Print], V Subbiah, I Brana, A Longhi, V Boni, JP Delord, A Awada, P Boudou-Rouquette, J Sarantopoulos, GI Shapiro, A Elias, R Ratan, C Fernandez, C Kahatt, M Cullell-Young, M Siguero, A Zeaiter, SP ChawlaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.